Narrow search
Showing 1 - 10 of 5,177
Cover Image
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011
also characterized by extensive regulation of almost every activity, from product development through manufacturing and …
Persistent link: https://www.econbiz.de/10014025576
Cover Image
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on …
Persistent link: https://www.econbiz.de/10010274913
Cover Image
Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - CESifo - 2010
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on …
Persistent link: https://www.econbiz.de/10008799730
Cover Image
Hospital competition with heterogeneous patient groups : incentives and regulation
Vomhof, Markus - 2016
Competing hospitals may not only use quality of service to attract patients but also their specialization profile. Applying a Hotelling-duopoly and interpreting respectively quality and specialization as vertical and horizontal differentiation, we analyze the optimal allocation in both...
Persistent link: https://www.econbiz.de/10011506836
Cover Image
Hospital competition with heterogeneous patient groups: Incentives and regulation
Vomhof, Markus - 2016
Competing hospitals may not only use quality of service to attract patients but also their specialization profile. Applying a Hotelling-duopoly and interpreting respectively quality and specialization as vertical and horizontal differentiation, we analyze the optimal allocation in both...
Persistent link: https://www.econbiz.de/10011507388
Cover Image
The Welfare Impact of Reducing Choice in Medicare Part D: A Comparison of Two Regulation Strategies
Lucarelli, Claudio; Prince, Jeffrey T.; Simon, Kosali - Department of Business Economics and Public Policy, … - 2009
of the average monthly premium in order to justify a regulation that allows only two plans per firm. However, this number …
Persistent link: https://www.econbiz.de/10008534096
Cover Image
Pharmaceutical regulation at the wholesale level and parallel trade
Birg, Laura - 2013
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by … wholesale margins enhance the manufacturerś ability to reduce competition from parallel trade in the destination country by …
Persistent link: https://www.econbiz.de/10010223101
Cover Image
Parallel imports and manufacturer rebates : evidence from Germany
Birg, Laura - 2019
pharmaceuticals on competition by parallel imports. First, I analyze the effect of a manufacturer rebate on competition by parallel … data set with prescription drugs with competition from parallel imports, I estimate the effect of the change in the … manufacturer rebate on competition by parallel imports. Estimation results suggest that an increase in the manufacturer rebate has …
Persistent link: https://www.econbiz.de/10011949028
Cover Image
Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark ; conference paper
Kaiser, Ulrich; Méndez, Susan; Rønde, Thomas; … - 2013 - This version: February 23, 2013
Reference prices constitute a main determinant of patient health care reimbursement in many countries. We study the effects of a change from an "external" (based on a basket of prices in other countries) to an "internal" (based on comparable domestic products) reference price system. We find...
Persistent link: https://www.econbiz.de/10010339324
Cover Image
How do drug prices respond to a change from external to internal reference pricing? : evidence from a Danish regulatory reform
Kaiser, Ulrich; Méndez, Susan J. - 2015
We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals using quasi-experimental data for Denmark which switched from external (where reimbursements are based on prices of similar products in foreign countries) to internal reference...
Persistent link: https://www.econbiz.de/10010467805